Posted by emmanuel98 on September 6, 2011, at 20:57:47
In reply to atypicals vs conventional neuroleptics, posted by Christ_empowered on September 6, 2011, at 11:54:46
My p-doc told me that geodon (according to something he read) has a 5% market share for APs and perphenezine has a 4% market share. So somebody is still prescribing the old drugs.
poster:emmanuel98
thread:995947
URL: http://www.dr-bob.org/babble/20110902/msgs/996051.html